{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:26:02Z","timestamp":1790043962710,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Belgian Fonds National de la Recherche Scientifique"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.vaccine.2015.05.005","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T14:42:31Z","timestamp":1431614551000},"page":"3179-3185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["The site of administration influences both the type and the magnitude of the immune response induced by DNA vaccine electroporation"],"prefix":"10.1016","volume":"33","author":[{"given":"Ga\u00eblle","family":"Vandermeulen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Vanvarenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ans","family":"De Beuckelaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefaan","family":"De Koker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Lambricht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Uyttenhove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Reschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Vanderplasschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Grooten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Pr\u00e9at","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.05.005_bib0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-4939-0410-5_13","article-title":"Plasmid fermentation process for DNA immunization applications","volume":"1143","author":"Carnes","year":"2014","journal-title":"Methods Mol Biol"},{"issue":"January (10)","key":"10.1016\/j.vaccine.2015.05.005_bib0115","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.vaccine.2004.09.001","article-title":"TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines","volume":"23","author":"Tudor","year":"2005","journal-title":"Vaccine"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2015.05.005_bib0125","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/mthe.2000.0117","article-title":"High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle","volume":"2","author":"Bettan","year":"2000","journal-title":"Mol Ther"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2015.05.005_bib0130","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1073\/pnas.96.8.4262","article-title":"High-efficiency gene transfer into skeletal muscle mediated by electric pulses","volume":"96","author":"Mir","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"December (1\u20132)","key":"10.1016\/j.vaccine.2015.05.005_bib0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jconrel.2007.08.010","article-title":"Optimisation of intradermal DNA electrotransfer for immunisation","volume":"124","author":"Vandermeulen","year":"2007","journal-title":"J Control Release"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2015.05.005_bib0140","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/gt.2010.46","article-title":"Therapeutic levels of erythropoietin (EPO) achieved after gene electrotransfer to skin in mice","volume":"17","author":"Gothelf","year":"2010","journal-title":"Gene Ther"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2015.05.005_bib0145","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/mt.2013.258","article-title":"Skin electroporation of a plasmid encoding hCAP-18\/LL-37 host defense peptide promotes wound healing","volume":"22","author":"Steinstraesser","year":"2014","journal-title":"Mol Ther"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2015.05.005_bib0150","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1006\/mthe.2002.0601","article-title":"IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma","volume":"5","author":"Lucas","year":"2002","journal-title":"Mol Ther"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2015.05.005_bib0155","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejpb.2011.02.001","article-title":"Antitumoral and antimetastatic effect of antiangiogenic plasmids in B16 melanoma: higher efficiency of the recombinant disintegrin domain of ADAM 15","volume":"78","author":"Daugimont","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2015.05.005_bib0160","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/156720106775197538","article-title":"Non-invasive immunization on the skin using DNA vaccine","volume":"3","author":"Cui","year":"2006","journal-title":"Curr Drug Deliv"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2015.05.005_bib0165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00232-010-9283-0","article-title":"Hollow microneedle arrays for intradermal drug delivery and DNA electroporation","volume":"236","author":"Daugimont","year":"2010","journal-title":"J Membr Biol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2015.05.005_bib0170","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.gt.3300628","article-title":"Superiority of the ear pinna over muscle tissue as site for DNA vaccination","volume":"5","author":"Forg","year":"1998","journal-title":"Gene Ther"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2015.05.005_bib0175","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.4161\/hv.22062","article-title":"What you always needed to know about electroporation based DNA vaccines","volume":"8","author":"Gothelf","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2015.05.005_bib0180","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.4161\/hv.25561","article-title":"Evaluation of immunogen delivery by DNA immunization using non-invasive bioluminescence imaging","volume":"9","author":"Petkov","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"September","key":"10.1016\/j.vaccine.2015.05.005_bib0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1876401000902010018","article-title":"Ear pinna: a privileged DNA electroporation site for inducing strong Th1 immune responses","volume":"2","author":"Ni","year":"2009","journal-title":"Open Cancer Immunol J"},{"issue":"December","key":"10.1016\/j.vaccine.2015.05.005_bib0190","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bioelechem.2013.11.002","article-title":"Intramuscular electroporation of a P1A-encoding plasmid vaccine delays P815 mastocytoma growth","volume":"100","author":"Vandermeulen","year":"2014","journal-title":"Bioelectrochemistry"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2015.05.005_bib0195","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jconrel.2012.01.035","article-title":"Highly potent delivery method of gp160 envelope vaccine combining lentivirus-like particles and DNA electrotransfer","volume":"159","author":"Vandermeulen","year":"2012","journal-title":"J Control Release"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2015.05.005_bib0200","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.4049\/jimmunol.154.11.5637","article-title":"Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro","volume":"154","author":"Gajewski","year":"1995","journal-title":"J Immunol"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2015.05.005_bib0205","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.4049\/jimmunol.178.11.6761","article-title":"Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor","volume":"178","author":"Naslund","year":"2007","journal-title":"J Immunol"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2015.05.005_bib0210","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/(SICI)1097-0215(19970127)70:3<349::AID-IJC17>3.0.CO;2-A","article-title":"The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen","volume":"70","author":"Uyttenhove","year":"1997","journal-title":"Int J Cancer"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15006192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15006192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T14:32:38Z","timestamp":1691677958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15006192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":20,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0264410X15006192"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The site of administration influences both the type and the magnitude of the immune response induced by DNA vaccine electroporation","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}